Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-07-06 @ 3:24 AM
Study NCT ID:
NCT05506969
Status:
COMPLETED
Last Update Posted:
2025-07-29
First Post:
2022-08-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
Sponsor:
Organization: